Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The normal human prostate does not significantly affect blood DHT levels.

Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The surgical technique of scalp advancement and pretrichial brow lift shortens the forehead and lifts brows, is good for women and transgender women with high foreheads, but not recommended for men and has some risks.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Facial contouring is crucial for the satisfaction and well-being of Chinese transgender females.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Proper planning and technique in upper-face feminization surgery are crucial to avoid complications and revisions.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.